AKT1 and thyroid gland carcinoma: In another study, the integrative analysis of aggressive thyroid carcinomas, including ATC and advanced DTC, revealed the frequent presence of TERT, AKT1, PIK3CA, and EIF1AX mutations in combination with BRAFV600E and RAS mutations in these advanced forms of thyroid cancers [73].